Living Guideline for Pediatric Concussion Care
Author(s) -
Dalton, Kristine,
Ash Kolstad,
Gargaro, Judith,
Esser, Michael,
DePompei, Roberta,
Shelina Babul,
Schneider, Kathryn,
Nick Reed,
Christine Provvidenza,
Margaret Sampson,
Gag, Isabelle,
Robinson, Michael,
Cairncross, Molly,
Goulet, Kristian,
Fremont, Pierre,
Howitt, Scott,
Haney, Erin,
Beauchamp, Miriam,
Russell, Kelly,
Purcell, Laura,
Wilcock, Ruth,
Yeates, Keith,
Meilssa Paniccia,
Zachary Tataryn,
Hung, Ryan,
Macartney, Gail,
Purtzki, Jacqueline,
Vassilyadi, Michael,
Wade, Shari,
Seguin, Ryan,
Fraser, Douglas,
Teige C. Bourke,
Osmond, Martin,
Hunt, Anne,
Glang, Ann,
van Ierssel, Jacquie,
Bayley, Mark,
Scratch, Shan,
Gioia, Gerard,
Giza, Christopher,
McFarland, Stephanie,
Shepherd, Heather,
Master, Christina L.,
Veronik Sicard,
Fait, Phil,
Carson, James,
Somers, Sara,
Wellington, Cheryl,
Ellis, Michael,
Kaylee Eady,
Dean, Stephanie,
Edwards, Carla,
Marshall, Shawn,
Bauman, Shan,
Jennifer Dawson,
AndréeAnne Ledoux,
Taylor, Taryn,
Gray, Janice,
Roger Zemek,
Leddy, John
Publication year - 2021
Publication title -
osf preprints (osf preprints)
Language(s) - English
DOI - 10.17605/osf.io/3vwn9
Subject(s) - concussion , guideline , medicine , medical emergency , poison control , injury prevention , pathology
> Diclofenac powder for oral suspension (Cambia®) No indication <18 years of age. Acute treatment of migraine attacks with or without aura in adults 18 years of age or older. No indication <18 years of age. Acute treatment of migraine attacks with or without aura in adults 18 years of age or older. Adult: 50 mg q24 hrs prn (max 15 doses/ month). *Note: the safety of taking a second dose has not been studied, as per the manufacturer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom